MARIZYME, INC. (MRZM) SEC Filings

Marizyme, Inc. approved and executed a general assignment for the benefit of creditors, transferring all or substantially all of its assets to an assignee. On April 9, 2026, the Board determined this assignment was in the company’s best interests and authorized an Assignment Agreement with Peter Hurwitz as assignee, which was signed on April 14, 2026. The company states this transaction constitutes an assignment for the benefit of creditors proceeding under Chapter 727, Florida Statutes, and it is reported under the Bankruptcy or Receivership and Disposition of Assets items.